20 1 9 A N N UA L REPORT
B E H I N D E V E RY R E S E A RC H AWA R D, E V E R Y S C H O L A R S H I P A N D E V E R Y G R A N T, THERE IS ONE SINGULAR AIM: I M PAC T I N G A N D I M P R OV I N G P AT I E N T C A R E .
Message from the SVS Foundation Chair
Michel S. Makaroun, MD Chair, SVS Foundation
CORE MISSION OF THE SVS F O U N D AT I O N To optimize the vascular health and well-being of patients and the public through support of research that leads to discovery of knowledge and innovative strategies, as well as education and programs, to prevent and treat circulatory disease.
D E A R F R I E N D S:
The SVS Foundation is a fundamental part of our Society, entrusted with supporting programs that advance our knowledge of vascular disease and improve the care delivery process to our patients and communities. Last year has seen a major push to raise awareness and financial support for the Foundation through the “Vascular Spectacular” gala. I thank you all for the tremendous support that you provided and encourage you to be free with any input that you think can make your Foundation better serve its mission. We are embarking this year on a process to restructure the governance and leadership structure, aiming to provide more stability and improve fund-raising efforts. Any thoughts are welcome. The SVS Foundation has been embracing change in its focus and reach. Over the last two years, it expanded its core mission to emphasize not just research but also education, awareness, disease prevention and public health. It is a quite natural transition because behind every research award, every scholarship and every grant there is one singular aim: impacting and improving patient care. Our surgeon-scientists are focused on results and securing additional funding, because their continued work might lead to a new treatment, intervention or understanding of vascular disease. They’re working toward the future. At the same time, our community practitioners are taking advantage of other SVS Foundation initiatives: patient education fliers in two languages plus the Community Awareness and Prevention Project grants. We just awarded the second set of these grants which are very much in line with our aims: to educate our patients, impact our communities for the better and improve vascular health. The SVS Foundation will continue to grow and change in response to its changing environment and that of the Society. I continue to be inspired by the imagination and dedication of my valued colleagues who work every day to improve patient care, today and in the future. Some of those colleagues are featured in these pages, explaining the connection between their SVS Foundation awards and their patients. Please read their stories. I encourage you to be very generous in supporting your Foundation as we aim to make it a more influential force in treating vascular disease and improving vascular health. Yours truly, Michel S. Makaroun, MD Chair, SVS Foundation
A productive year— Our numbers tell the story
? 2019
SVS FOUNDATION FISCAL YEAR HIGHLIGHTS
37
percent of Foundation income contributed by individuals & departments
11
88 10% 2%
percent of donations go directly to support awards
fundraising
administration
44% External Society and Foundation contributors
19%
from corporate support
percent of Active and Senior members in North America who are contributors
READ HOW
$6,863,785* Total liabilities and equity
* Includes cash, investments and value of pledges for future support
YOUR DONATIONS ARE BEING PUT INTO PR ACTICE I N T H E PA G E S T H AT F O L LO W
100
percent of SVS Foundation Board members who are contributors
1
We have all watched the concentric circles of ripples when a droplet or a stone lands in the water. That first transformation in the water’s surface creates ripples that then recreate themselves, over and over, moving outward across the water’s surface, eventually lapping up against a distant shore. LIKE RIPPLES, THE MORE THAN $13 MILLION IN GRANTS AWARDED BY THE SVS FOUNDATION OVER THE PAST THREE DECADES HAVE EXTENDED FAR BEYOND THE FIRST SPLASH OF INNOVATION TO IMPACT THE LIVES OF PATIENTS AND THOSE WHO PROVIDE THEIR CARE.
In the 2019 SVS Foundation Annual Report, you will learn how award recipients have used their grant monies to change and improve the way we heal our patients. The SVS Foundation provides that crucial first splash of support—and we can only continue to do that with your support.
2
SVS F OU N DATI O N
| 20 19 A N N UA L R E P O RT
Luke Brewster, MD, PhD
Emory University, Atlanta, Ga. SVS FOUNDATION AWARD
K08 Mentored Clinical Scientist Research Career Development Award Resident Research Prize, now the Resident Research Award One of my patients wrote me a very thoughtful note about how when he became a patient, he had no idea how much peripheral artery disease would end up affecting his life. He has refractory pain that limits his ability to care for his grandkids. He mentioned the song, “Walk a Mile in My Shoes,” and how he wishes he could walk a mile in his own shoes. His shoes last longer now and he wishes he could wear
them out like he used to. He’s a wonderful patient and it’s patients like him that I think of during my research and why I am so grateful for the matching grant funds for my K08 from the SVS Foundation. We’ve been able to identify some unique mechanisms of flow mediated arterial stiffening that may have translational benefit to our patients. Most excitingly, we’ve also been able to demonstrate that these mechanisms can be identified in the arteries of our PAD patients where they have blockages. The blood will come around through collateral pathways with an up and down flow pattern that promotes not only focal artery stiffening but also atherosclerosis. Arterial stiffening can be modified by exercise and it’s thought that there are molecular mechanisms in that pathway that can be treated pharmacologically or through different therapies. My laboratory helps to discover these therapies and then to test whether they are modifiable or not.
MY G R AN DMOTH ER HAD DIAB ETES AN D SU FFERED A LOT OF NON - H E ALI NG WOU N DS . THAT DROVE M E TO FOCUS A LOT ON PRE VENTI NG SOM E OF TH ESE COM PLIC ATIONS .
Katherine Gallagher, MD
University of Michigan SVS FOUNDATION AWARD
Mentored Clinical Scientist Research Career Development Award (K08) My research focuses on diabetes and diabetic wound healing. I focus on particular cells’ macrophages that are involved in inflammation and how those cells are altered in conditions like diabetes. My research also extends into looking very specifically at how these cells are more inflammatory, and into other conditions such as peripheral arterial disease and aneurysm formation. I look at how these cells are altered through epigenetic mechanisms and try to restore some of the normal function so that we can hopefully improve patient care and improve outcomes for a lot of these patients, who unfortunately wind up needing amputations because our treatments are not optimal.
I am very, very passionate about this specific line of research. I have several close family members, including my grandmother, who suffered from Type 2 diabetes, and she had a lot of the secondary complications of diabetes, such as non-healing wounds. This has driven me from a very early age to be very involved in the diabetic community and to also try to focus a lot of my life’s work and my research on looking for new ways to advance therapies to hopefully prevent some of these secondary complications. Each grant has given me unique opportunities and allowed me to expand my ability to touch others through my research. These grants—for which I am grateful—are very important. They continue to fund young investigators to allow us as a group and as a society to continue to advance cures for vascular disease. And they continue to advance training opportunities so that we have surgeon-scientists in the future.
3
Philip Goodney, MD
Dartmouth Hitchcock Medical Center, Lebanon, N.H.
to care. What were the differences in the way vascular care was provided in these different areas? How did these differences translate into different outcomes?
Multicenter Clinical Studies Planning Grant
Thanks to the SVS Foundation, I was given critical funding that supported the early days of my research on this. I received the Clinical Research Seed Grant and an NIH award, which not only helped develop our research program, but also gave us the ability to train others to assist in our research. The early, critical support provided by the SVS Foundation was a catalyst for helping us develop a multi-center focusing on impactful research.
At the beginning of my career, I was interested in studying the different ways vascular care was provided to patients who were at risk of amputation. I figured that in some areas of the country, you could find very invasive and intensive vascular care, whereas in other regions it was difficult for patients to even gain access
We ended up finding that some vascular care is better than none, but cost-effective strategies can help patients in any setting. Over the last 10 years, we’ve had the pleasure of sharing our research with colleagues across the country. Without the early support of the Foundation, this impact wouldn’t have been possible.
SVS FOUNDATION AWARD
Clinical Research Seed Grant Award Mentored Clinical Scientist Research Career Development Award (K08)
I N SOM E ARE A S OF TH E COU NTRY YOU FI N D I NTENSIVE VA SCU L AR C ARE AN D I N OTH ER REG IONS IT’ S DI FFICU LT FOR PATI ENTS TO E VEN GAI N ACCESS TO C ARE .
Misty D. Humphries, MD
University of California Davis Medical Center
SVS FOUNDATION AWARD
Clinical Research Seed Grant 2016 Project: Developing Comprehensive Care for Patients with Lower Extremity Ulcers Through Telemedicine Research Career Development Travel Award SVS Foundation and ACS Mentored Patient-Oriented Research Career Development Award
4
The SVS seed grant allowed me to treat rural patients through telemedicine. One of the best times of my day is doing a consult with one of my TOS patients. Most recently we had a wonderful patient who plays pickle ball. She had an exceptional result after her surgery, even though she had been debilitated for several years. It was hard for her to drive the 2.5 hours to our clinic, so SVS F OU N DATI O N
| 20 19 A N N UA L R E P O RT
telemedicine was a great opportunity. Our whole clinic staff could see her on the screen, smiling, raising her arms up and just ecstatic. That really means a lot. The greatest thing about my SVS Foundation funding is that the work I do touches patients every day. These are patients that have become my family. Several years ago, I did the first bypass on a lovely woman from the South. She knew that I was from Texas and that I rarely got really good Southern food in Northern California. When she came to see me, she would always bring me various types of Southern delicacies. That was always a special time. This year, she came in with a very severe case of arterial thrombosis and it ended up in her demise. Her family and I had a long hug and talked a lot about what a wonderful woman she was. I think for her, and for her family, knowing that they were working with a physician who was part of the SVS and doing SVS research really comforted them. They felt they were working with somebody who was on the cutting edge of vascular surgery. My grants have helped me investigate ways to improve mortality for these patients.
Jeffrey Kalish, MD Boston Medical Center, Boston, Mass.
SVS FOUNDATION AWARD
E.J. Wylie Traveling Fellowship (Dr. Jeffrey Kalish’s surgical experiences in the aftermath of the 2013 Boston Marathon bombing led him to seek better ways— not necessarily surgical only—to help amputation patients. He wanted to witness high-level military amputee surgical care and rehabilitation and bring that knowledge home.)
While I learned a tremendous amount during my time away from Boston, one incredibly valuable aspect of my learning has been what I have brought back to BMC: a multidisciplinary team … to formalize and standardize best practices to benefit BMC amputation patients. STRONG (Surgery To Rehab Ongoing Needs Group) continues to strive toward the ultimate goal of improving
and coordinating care for amputation patients and their families as they transition from the hospital setting to rehabilitation. This group has brought together surgeons from multiple specialties, in addition to representatives from nursing, psychiatry, physical therapy, social work, patient advocacy and pastoral care. My visits to Walter Reed for hands-on learning have been career-changing and have undoubtedly improved my surgical knowledge and skills. My involvement as a clinician with numerous amputee advocacy and specialty groups has given me a newfound appreciation for the challenges my patients and their families face every day in the current health care system. I am confident that as I spread my acquired knowledge to the SVS, and ultimately to other surgical and medical professional societies, I will achieve the goals I set forth in my application: creating a military-civilian bridge for the exchange of information, being an active leader in the creation of the optimal systems of health care for amputees, and simply becoming a better physician and vascular surgeon for all of my patients.
MY I NVOLVEM ENT WITH AM PUTEE G ROU PS HA S G IVEN M E A N E WFOU N D APPRECIATION FOR TH E CHALLENG ES TH E Y AN D TH E I R FAM I LI ES FACE E VERY DAY I N TH E CU RRENT H E ALTH C ARE SYSTEM .
C. Keith Ozaki, MD
Brigham and Women’s Hospital, Harvard Medical School Boston, Mass. SVS FOUNDATION AWARD
E.J. Wylie Traveling Fellowship Mentored Clinical Scientist Research Career Development Award (K08) Receiving the SVS Foundation Mentored Clinical Scientist Research Career Development Award propelled my career in many ways. I’ve been able to study the way blood vessels respond to physical forces and, more recently, the way food consumption before surgery affects the response to surgical trauma. My research has evolved over the years, but one of the most rewarding things about the SVS Foundation’s support has been the ability to impact the lives of others.
I’ll always recall one patient who gave me a buckeye after his treatment. This patient had severe vascular disease and end stage renal disease. He needed bypasses in both legs and a graft in his arm for renal replacement therapy. Things weren’t looking so good, but to my surprise these grafts lasted many years and his treatment was very successful. An important lesson this patient taught me was that some people respond differently to treatment. We always remember cases that fail and try to understand why, but there are patients who do well. I keep the buckeye on my desk to remind me of this, and it motivates me to work harder in the lab, tweak the biology and analyze the responses after surgery so all patients have better outcomes. The SVS Foundation enables vascular surgeons to pursue groundbreaking research, which in turn attracts the best and the brightest medical students and residents to the field. It plants the seed needed to accelerate the pace of conquering vascular disease and provides hope for more positive outcomes.
5
Gala Was ‘Spectacular’ Indeed! Dr. Michel Makaroun could not be more delighted with the “Vascular Spectacular” gala, an addition to the 2019 Vascular Annual Meeting which is sure to be repeated for years to come. And it raised tens of thousands of dollars for the SVS Foundation’s grants and initiatives.
Indeed, the gala was sold out nearly six weeks ahead of time, with extra tables squeezed in to accommodate as many people as possible. Members contributed more than 70 items for live and silent auctions. The crowd included all ages and attendees danced so enthusiastically the DJ apologized for ending the evening.
“It was fun from start to finish,” he said. The evening featured entertainment, including the incomparable Dr. Peter Gloviczki, who wowed the crowd with his magic show; a silent online auction and live auction that featured plenty of spirited bidding, and a Paddle Raise, all to raise funds for research grants, scholarships, public awareness initiatives and community projects.
“I can only say it was an unqualified success,” smiled Dr. Makaroun. “All in all, I think it was a positive step in making the annual meeting more than just a scientific meeting,” he said, “while also raising money for the SVS Foundation.”
Immediate Past President Dr. Makaroun has long wanted a social event at VAM to bring everyone together. He proposed the gala in place of the traditional President’s Reception. When the concept received overwhelming support, he recruited “great people with insight on how to put a party together,” chaired by Drs. Cynthia Shortell and Ben Starnes.
Since handing over his gavel to Dr. Hodgson, Dr. Makaroun now assumes the chairmanship of the SVS Foundation. How will he top the success of his 2019 gala?
SVS President Dr. Kim Hodgson has vowed the gala will return in 2020.
Nationwide Photographers
The answer was quick: be able to host more people in 2020. “Hopefully that will be the way to top this year!”
6
SVS F OU N DATI O N
| 20 19 A N N UA L R E P O RT
COMMUNIT Y GRANTS
Three SVS members are hard at work improving the health of members of their communities. Drs. Uwe Fischer, Soma Brahmanandam and Leigh Ann O’Bannion received SVS Foundation Community Awareness and Prevention Project grants at the 2019 Vascular Annual Meeting. The awards debuted in 2018 and are part of the Foundation’s expanded mission to include projects that impact vascular health, awareness and prevention. Recipients must be community-based vascular surgeons. Each received up to $10,000 for their community-based initiatives.
Uwe Fischer, MD, PhD, plans to offer workplace-based vascular education and screenings to the 25,000 employees of the six largest employers in eastern Connecticut. Participants will participate in information collection, with various stations set up for completion of questionnaires, capturing not only blood samples but also a variety of vital signs, obtaining ankle-brachial indices plus ultrasound screenings for carotid artery disease. Dr. Fischer will facilitate building teams of patients, family members, friends and a physician to follow programs and protocols for reducing or eliminating vascular disease risk factors. The goal is to help participants quit smoking; get treatment for high blood pressure, diabetes and high cholesterol; and start exercise programs. Employers will offer incentives for reaching individual goals and participants will be urged to extend the program outside the workplace.
Learn more about the grants at vsweb.org/CommunityGrants. The 2020 deadline is March 1.
Soma Brahmanandam, MD, MPH, will educate the Queens (New York) community about peripheral vascular disease. There are no such programs in New York City and she believes that, “given the negative impact on morbidity and quality of life, raising awareness is crucial.” The initiative will include an educational campaign to raise awareness, a preventative strategy program and a PVD Support Group. Her hospital includes many patients from a multiethnic, immigrant, working-class background. They typically have a robust support network and a proactive attitude towards health, but too often wait for care until they experience tissue loss and/or gangrene, she said. Her initiative will cover preventative care, exercise therapy, nutrition and management of risk factors and includes collaboration with nutritionists, primary care physicians, endocrinologists, plus exercise therapists and teachers. An earlier successful effort on early identification of acute limb ischemia convinced her that education plays a key role in raising awareness. “Empowering individuals with knowledge will guide them to seek care sooner and help decrease the incidence of severe presentations of PVD,” she said.
Leigh Ann O’Banion, MD: Dr. O’Banion, a vascular surgeon in Fresno County, California, wants to improve the care of limb salvage patients, especially those requiring major lower extremity amputations. She developed the Lower Extremity Amputation Pathway project for patients who require amputations in the central San Joaquin Valley, which is underserved in vascular care, she said. This pathway includes perioperative patient education and multidisciplinary team collaboration focused on minimizing hospital length of stay and returning to functional ambulation. Included are two community-based rehabilitation facilities plus prosthetic centers and a physical therapy center. She has hosted outreach events for amputees and their families on this project and available resources including an amputation prevention center, which has improved screening in PAD patients and diabetics to enhance limb salvage. “Fresno has previously ranked No. 1 in California for amputation rate, and there is a true need for the LEAP protocol and improved outcomes,” said Dr. O’Banion. She hopes success in Fresno will lead to implementing LEAP nationwide.
7
2019 SVS FOUNDATION AWARD WINNERS
Lena Vodovotz University of Pittsburgh SPONSOR: Ulka Sachdev, MD
SVS Foundation and American College of Surgeons Mentored Clinical Scientist Research Career Development Award (K08) Student Research Fellowship Tiffany Bellomo University of Michigan Medical School SPONSOR: Matthew Corriere, MD Sarah Bessen Dartmouth-Hitchcock Medical Center SPONSOR: Bjoern D. Suckow, MD, MS Matthew Chrencik University of Maryland School of Medicine SPONSOR: Brajesh K. Lal, MD Erin Driscoll Lerner Research Institute, Cleveland Clinic SPONSOR: Linda Graham, MD Arash Fereydooni Yale School of Medicine SPONSOR: Alan Dardik, MD, PhD Ryan Foley University of Nebraska Medical Center SPONSOR: B. Timothy Baxter, MD Brandon Glousman George Washington University SPONSOR: Bao-Ngoc Nguyen, MD Linh Ngo Khanh Northwestern University Feinberg School of Medicine SPONSOR: Karen J. Ho, MD Jason Park Boston Medical Center SPONSOR: Jeffrey Siracuse, MD
Jean Marie Ruddy, MD Medical University of South Carolina Stretch-induced VSMC Signaling in HTN and AAA
SVS Foundation and ACS Mentored Patient-Oriented Research Career Development Award (K23) Misty D. Humphries, MD University of California (Davis) Health System Evaluating Implementation of Comprehensive Assessment and Telemedicine Consultation to Prevent Amputations for Patients with Lower Extremity Ulcers in Rural Health Clinics
Bridge Grant Wei Zhou, MD University of Arizona PROJECT: Establishing a clinical research unit to focus on diabetes-related atheroprogression and complication of diabetes
E.J. Wylie Traveling Fellowship Douglas Jones, MD Boston University School of Medicine PROJECT: Visiting centers with a multidisciplinary team approach to managing CLI
Clinical Research Seed Grant
Muzammil Hussain Syed St. Michael’s Hospital, Toronto, Canada SPONSOR: Mohammad Qadura, MD, PhD
Sikandar Zaman Khan, MD SUNY Buffalo Validation of Plateletcrit as a Marker of Platelet Reactivity by Comparing It with Verify Now Reactivity Assays
Gregory Tsougranis White River Junction Veterans Administration Medical Center SPONSOR: David H. Stone, MD
Shirling Tsai, MD University of Texas Southwestern Role of Provider Feedback in Home-Based Walking Programs Utilizing Smart Devices
8
SVS F OU N DATI O N
| 20 19 A N N UA L R E P O RT
Efthymios Avgerinos, MD (Awarded following a competition during the 2019 Vascular Annual Meeting) University of Pittsburgh The Value of Screening for “High on Treatment Platelet Reactivity” in Patients undergoing Lower Extremity Arterial Endovascular Interventions
Resident Research Award Frank Davis, MD University of Michigan Epigenetic Modification to the Prostaglandin E2 (PGE2) Pathway Regulates Inflammation and Host Defense in Diabetic Wound Healing MENTOR: Katherine Gallagher, MD, University of Michigan
Research Career Development Travel Award Young Erben, MD Mayo Clinic, Jacksonville, Fla. Claire Griffin, MD University of Utah
Community Awareness and Prevention Project Practice Grant Soma Brahmanandam, MD, MPH, FACS, RPVI Mount Sinai Queens Hospital PROJECT: PAD Vascular Education and Awareness Leigh Ann O’Banion, MD University of California, San Francisco PROJECT: Lower Extremity Amputation Pathway (LEAP) Protocol Uwe Fischer, MD Lawrence and Memorial Hospital, New London, Conn. PROJECT: Vascular Health Challenge workplace program
SVS Foundation Award Opportunities Vascular Research Initiatives Conference Trainee Award Edmund Chen, MD Resident Physician-General Surgery, Northwestern University Feinberg School of Medicine ABSTRACT TITLE: Microbial Colonization Restores Neointimal Hyperplasia Development after Arterial Injury in Germ-Free Mice MENTOR: Karen Ho, MD Peter Kip, MD Research Fellow, Brigham and Women’s Hospital, Harvard Medical School ABSTRACT TITLE: Periprocedural Hydro-gen Sulfide Therapy Impairs Vascular Remodeling and Improves Vein Graft Patency MENTOR: C. Keith Ozaki, MD Constance Mietus, PhD UNMC MD/PhD Scholar, Third-Year Medical Student, University of Nebraska Medical Center ABSTRACT TITLE: Microvascular Pathology Influences Walking Performance in Patients with Peripheral Artery Disease MENTORS: Iraklis Pipinos, MD; George Casale, PhD Thomas Sorrentino, BS Medical student, University of California, San Francisco ABSTRACT TITLE: Circulating Exosomes in PAD Patients: Disease Severity Correlates with Effects on Vascular Cell Migration and mi-RNA Content MENTOR: Michael Conte, MD
SVS FOUNDATION AWARD
Research Career Development Travel Award VISIT:
Andrea Obi, MD University of Michigan PROJECT: Impact of Bone Marrow Progenitor Cells’ Epigenetic Memory on Venous Thrombus Formation and Resolution
August 15, 2019
vsweb.org/CareerTravel
Mentored Research Career Development Awards
NIH K Award Deadlines
VISIT:
vsweb.org/MentoredResearch VRIC Trainee Award VISIT:
VISIT:
January 15, 2020
vsweb.org/ResidentResearch
Student Research Fellowship VISIT:
January 7, 2020
vsweb.org/VRICScholarship
Resident Research Award
February 1, 2020
vsweb.org/StudentResearch
Clinical Research Seed Grant
March 1, 2020
VISIT:
vsweb.org/ClinicalResearchSeedGrant E.J. Wylie Traveling Fellowship VISIT:
Wylie Scholar Award (with Vascular Cures)
APPLICATION DEADLINE
vsweb.org/WylieTravel
Community Awareness and Prevention Project Grant VISIT:
March 1, 2020
vsweb.org/CommunityGrants
Wylie Scholar Award VISIT:
March 1, 2020
March 2, 2020
vsweb.org/WylieScholar
9
T
he Foundation’s Legacy Program includes those who
LEGACY PROGR AM DONORS
have contributed a total of $10,000 or more to the
SVS Foundation during their lifetime. They are honored in perpetuity for their commitment to the specialty.
The Legacy Program is grateful to every category of donor in this program: Benefactor’s Circle ($10,000 - $24,999)
Founder’s Circle
Director’s Circle
American College of Surgeons Anonymous Donor Joan L. and Julius H. Jacobson II
George Andros, MD Arthur I. Auer, MD Richard P. Cambria, MD Alexander W. Clowes, MD† Michael C. Dalsing, MD Susan Detweiler, MD Division of Vascular and Endovascular Surgery, Massachusetts General Hospital Eastern Vascular Society Nicholas D. Garcia, MD Vivienne J. Halpern, MD New England Society for Vascular Surgery C. Keith Ozaki, MD William H. Pearce, MD Southern Association for Vascular Surgery Daniel B. Walsh, MD and Teri Walsh, RN
($500,000 – plus)
William J. von Liebig Foundation Director’s Circle ($25,000-$49,999)
Chairman’s Circle ($100,000 - $499,999)
President’s Circle ($50,000-$99,999)
Edwards Vascular Foundation James DeBord, MD
Chairman’s Circle ($100,000 - $499,999)
Peter and Karen Lawrence
Founder’s Circle ($500,000+)
President’s Circle
These contributors are leaders who best understand our specialty’s critical need for innovative researchers and the need to provide patient education for prevention of circulatory disease.
($50,000 - $99,999)
Midwestern Vascular Surgical Society Society for Clinical Vascular Surgery Western Vascular Society
($25,000 - $49,999)
Benefactor’s Circle (10,000 - $24,999)
* If you note any omissions or corrections, please contact Allison Stanis at SVSFoundation@ vascularsociety.org or 312-334-2352. Early contributions to the Lifeline Foundation or the American Vascular Association® may not be reflected.
† Indicates deceased 10
SVS F OU N DATI O N
John Abele Ali AbuRahma, MD K. Ramesh Adiga, MD Samuel S. Ahn, MD Dennis F. Bandyk, MD Robert C. Batson, MD B. Timothy Baxter, MD John J. Bergen, MD† Victor M. Bernhard, MD Paul S. Brown Jr., MD Allan D. Callow, MD† Joseph E. Carney, MD
| 20 19 A N N UA L R E P O RT
G. Patrick Clagett, MD Jon R. Cohen, MD E. Stanley Crawford, MD† Jack L. Cronenwett, MD Ronald L. Dalman, MD Herbert Dardik, MD R. Clement Darling III, MD Mark G. Davies, MD, PhD David Deakins, MD Michael E. DeBakey, MD† Dominic A. DeLaurentis, MD†
Ralph G. DePalma, MD James A. DeWeese, MD† R. Howard Dobbs, MD Magruder C. Donaldson, MD William H. Edwards, MD Calvin B. Ernst, MD† Ronald M. Fairman, MD Rumi Faizer, MD William R. Flinn, MD Thomas L. Forbes, MD Julie Ann Freischlag, MD
Bruce L. Gewertz, MD Gary Giangloa, MD Peter Gloviczki, MD John F. Golan, MD Richard M. Green, MD Lazar J. Greenfield, MD Thomas J. Greenfield, MD Roger T. Gregory, MD John W. Hallett, Jr, MD Norman R. Hertzer, MD Robert W. Hobson II, MD† Glenn C. Hunter, MD Anthony M. Imparato, MD Bengt L. Ivarsson, MD George Johnson, Jr., MD† Robert L. Kistner, MD Larry W. Kraiss, MD Marvin E. Kuehner, MD Robert P. Leather, MD Stephen E. Lee, MD Frank W. LoGerfo, MD Joseph G. Magnant, MD William T. Maloney, MD John A. Mannick, MD Rebecca Maron, CAE Kenneth E. McIntyre Jr, MD Joseph L. Mills Sr, MD R. Scott Mitchell, MD Gregory L. Moneta, MD Wesley S. Moore, MD Robert W. Oblath, MD John L. Ochsner, MD† Kenneth and Joy Ouriel Malcolm Perry, MD† John J. Ricotta, MD Thomas S. Riles, MD Gary R. Seabrook, MD Alexander D. Shepard, MD Gregorio A. Sicard, MD Robert B. Smith III, MD Ronald J. Stoney, MD David S. Sumner, MD† George T. Sugiyama, MD Vascular & Endovascular Surgery Society Frank J. Veith, MD Fred Weaver, MD Jock R. Wheeler, MD Anthony D. Whittemore, MD Samuel J. Williams, MD James S. T. Yao, MD, PhD Robert M. Zwolak, MD, PhD
The SVS Foundation thanks the following contributors for their generous support.
ORGANIZATION DONORS
Contributions received from April 1, 2018, through May 15, 2019
SURGERY DEPARTMENT CONTRIBUTORS
SOCIETY CONTRIBUTORS
University of Massachusetts Medical Center, Division of Vascular and Endovascular Surgery
Intersocietal Accreditation Commission
FOUNDATION CONTRIBUTORS
Edwards Vascular Foundation Jewish Federation of St. Louis von Liebig Foundation
American College of Surgeons Midwestern Vascular Surgical Society New England Society for Vascular Surgery CORPORATE CONTRIBUTORS
Bismarck Farms Inc. BTG International Inc. Gore & Associates, Inc. Nunemaker - Ross Inc.
SVS Foundation thanks and appreciates
INDIVIDUAL DONORS
all who contribute. The following includes individuals and Donor Advised Funds who made contributions to the SVS Foundation between April 1, 2018, and May 15, 2019.
GREATEST NEED (Annual Fund)
Babak Abai, MD Ahmed M. Abou-Zamzam Jr., MD Christopher J. Abularrage, MD Ali F. AbuRahma, MD John G. Adams Jr., MD, FACS John A. Adeniyi, MD, FACS Riad Adoumie, MD Rana Afifi, MD Francesco A. Aiello, MD
Donald L. Akers, MD Jose I. Almeida, MD George Almeida, MD Iden Andacheh, MD James Nelson Antezana, MD Edward J. Arous, MD Elias J. Arous, MD Shipra Arya, MD, SM, FACS Bernadette Aulivola, MD Faisal Aziz, MD Julius W. Babb, MD Martin R. Back, MD William H. Baker, MD Donald T. Baril, MD
Carey L. Barry, MHS, PA-C, MT Neal R. Barshes, MD, MPH Tal Bash, MD Alexandre Battilana, MD Bernard Timothy Baxter, MD Hernan A. Bazan, MD, FACS Carlos Bechara, MD Adam W. Beck, MD Michael Belkin, MD Marshall E. Benjamin, MD Thomas M. Bergamini, MD Scott S. Berman, MD, MHA Thomas R. Bernik, MD, FACS Irwin M. Best, MD
11
Devinder S. Bhatia, MD Christian Bianchi, MD Seth Barak Blattman, MD John Blebea, MD, MBA Suellen Stevam Timotheo Bonadiman, MD April J. Boyd, MD, PhD, FRCSC Thomas E. Brothers, MD Paul Sherman Brown Jr., MD Chrystal Ann Buchanan, PA-C Jason S. Burgess, MD Patricia Burton, MS Keith D. Calligaro, MD Marcio Wilker Soares Campelo, MD, MSc, PhD Alfio Carroccio, MD Vitor Cervantes Gornati, MD, PhD Bill K. Chang, MD Kirk Charles, MD David Maurice Chatman, MD William Darrin Clouse, MD Salomon Cohen, MD FACS Dawn M. Coleman, MD Paul S. Collins, MD Peter Connolly, MD Sheila M. Coogan, MD Rachael Coyle Paul Crisostomo, MD, RPVI, FACS Jack L. Cronenwett, MD Luis Mariano Cruz Marquez Rico, MD Robert F. Cuff, MD Leslie D. Cunningham, MD, PhD John A. Curci, MD Carlo A. Dall’Olmo, MD Ronald L. Dalman, MD Michael C. Dalsing, MD Alan Dardik, MD, PhD Herbert Dardik, MD R. Clement Darling III, MD Mark G. Davies, MD, PhD Luis R. Davila-Santini, MD Antonio Carlos De Assis Filho, MD Alan M. Dietzek, MD Carlos E. Donayre, MD Melissa J. Donovan, MD Danielle Doucet, MD Adam J. Doyle, MD Audra A. Duncan, MD Joseph R. Durham, MD Matthew J. Eagleton, MD Matthew S. Edwards, MD
12
SVS F OU N DATI O N
Sean English, MD Young Erben, MD Mark K. Eskandari, MD Jaime Gerardo Estrada, MD Yana Etkin, MD Ronald M. Fairman, MD Ziad Fayad, MD Robert J. Feezor, MD Beejay Feliciano, MD Luis Mariano Ferreira, MD, PhD Robert W. Fincher, DO Thomas L. Forbes, MD Julie Ann Freischlag, MD Rogerio Cerqueira Garci Freitas, MD William R. Fry, MD Patricia C. Furey, MD Dennis R. Gable, MD Yves A. Gabriel, MD Katherine A. Gallagher, MD Justin Galovich, MD Nicholas D. Garcia, MD Nicholas J. Gargiulo III, MD Robert M. Gasior, MD James R. Gebhart, DO Stephen M. Gemmett, MD Gurpreet Gill, MD Julia Glaser, MD Natalia Glebova, MD, PhD, FACS, FSVS James M. Goff Jr., MD Michael A. Golden, MD Philip P. Goodney, MD Prem C. Gupta, MD Raul J. Guzman, MD Kevin D. Halow, MD Vivienne J. Halpern, MD, FACS Daniel K. Han, MD, FACS, RPVI David C. Han, MD Sachinder S. Hans, MD Linda M. Harris, MD Joseph P. Hart, MD Ravishankar Hasanadka, MD Caitlin Whitney Hicks, MD, MS Anil P. Hingorani, MD Kim J. Hodgson, MD York N. Hsiang, MD Kakra Hughes, MD Glenn C. Hunter, MD Benjamin M. Jackson, MD Ashish Kumar Jain, MD James Jen, MD Jeffrey Jim, MD, MPHS
| 20 19 A N N UA L R E P O RT
Jason M. Johanning, MD Brad L. Johnson, MD William D. Jordan Jr., MD Dejah R. Judelson, MD Vikram S. Kashyap, MD Gregory C. Kasper, MD Neelima Katragunta, MD, FACS Gregory J. Kechejian Edwin Kendrick, MD Melina R. Kibbe, MD Terry A. King, MD Alison Kinning, MD Stanley R. Klein, MD Sarah Elizabeth Koch, MD Issam Koleilat, MD Jared Kray, DO Scott Kujath, MD Chris LaGraize, MD Russell C. Lam, MD Robert A. Larson, MD Adriana Laser, MD Cheong J. Lee, MD Marlon Adrian Lee, MD Michael A. Leke, MD Gary W. Lemmon, MD Joyce Lu, MD Sarah Lucas, MD Ying Wei Lum, MD Sean P. Lyden, MD Richard A. Lynn, MD, FACS, RPVI Michel S. Makaroun, MD M. Ashraf Mansour, MD Megan Irene March, MD Silviu C. Marica, MD William A. Marston, MD John H. Matsuura, MD Mark A. Mattos, MD, FACS Stacey Mazzacco, M.D. Robert A. McCready, MD James T. McPhee, MD Nelson S. Menezes, MD Louis M. Messina, MD Erica Leith Mitchell, MD, MEd Nicola Molinaro J. Sheppard Mondy III, MD Gregory L. Moneta, MD Samuel R. Money, MD Michael Nagel, MD Massimo Mark Napolitano, MD Ramesh C. Narayanagowda, MD Peter R. Nelson, MD, MS Todd J. Neuberger, MD Gary Nishanian, MD
Andrea Obi, MD Cassius Iyad N. Ochoa Chaar, MD, MS David J. O’Connor, MD Paul Lawrence O’Donnell, DO Ricardo de Avila Oliveira, MD Gustavo Paludetto Oliveira, MD William Oppat, MD Frank T. Padberg Jr., MD Ramesh Paladugu, MD James Pan, MD Federico E. Parodi, MD Carlos Eduardo Parra, MD Marc A. Passman, MD Benjamin J. Pearce, MD, FACS Bruce Alan Perler, MD, MBA Brian G. Peterson, MD Peyser-Shortell Gifting Giancarlo Piano, MD Kristen Piazza, MSPAS, PA-C Edward J. Plecha, MD Frank B. Pomposelli, MD Elina Quiroga, MD Joseph D. Raffetto, MD Kevin B. Raftery, MD Ravi Rajani, MD Seshadri Raju, MD Denis P. Raleigh, MD Daniel J. Reddy, MD Michael A. Ricci, MD James W. Richardson, MD David A. Rigberg, MD Aksim Rivera, MD Andrew B. Roberts, MD Sean P. Roddy, MD David L. Rollins, MD Peter J. Rossi, MD Timothy S. Roush, MD Jean Ruddy, MD Fred W. Rushton Jr., MD William L. Russell, MD Patrick C. Ryan, MD Ulka Sachdev, MD Hossain Said-Mahmoudian, MD Timur P. Sarac, MD Andres Schanzer, MD Marc L. Schermerhorn, MD Gary R. Seabrook, MD Piergiorgio G. Settembrini, MD Kay Severinsen Murray L. Shames, MD Kyla Rae Shelton, MD Lynn H. Shin, MD Paula Shireman, MD Shutze Giving Fund
Direct Dollars to Favorite Fund The SVS Foundation provides donors the opportunity to direct their dollars to specific areas of interest. A contributor could have the zeal to fund the SVS Foundation’s core mission of research, or the new community initiatives, or simply the area of greatest need. The SVS Foundation funds include: GREATEST NEED (Annual Fund)
DISASTER RELIEF FUND
Gifts to this unrestricted fund will ensure that there will always be a resource to address projects that need funding.
This fund provides short-term emergency assistance and longer-term aid for vascular surgery practices and vascular patients in disaster-devastated communities.
AWARENESS AND PREVENTION (Community Health Initiatives)
ALEXANDER W. CLOWES DISTINGUISHED LECTURE FUND
Donations support our expanded mission in disease prevention, patient education and public awareness.
Honor the memory of our colleague and internationally recognized vascular surgeon-scientist, Dr. Alexander W. Clowes, by supporting the annual lecture at the Vascular Research Initiatives Conference.
RESEARCH GRANTS
Contributions support the SVS Foundation’s core mission—to crucial vascular research that improves patient health. Awards support researchers at all levels of their careers.
Gregorio A. Sicard, MD Anton N. Sidawy, MD, MPH Matthew Sideman, MD Jessica P. Simons, MD, MPH Niten Singh, MD Michael J. Singh, MD Mahalingham Sivakumar, MD Christopher L. Skelly, MD Kenneth M. Slaw, PhD Christopher J. Smolock, MD Maurice M. Solis, MD Michael Clarkston Soult, MD Sunita D. Srivastava, MD Benjamin W. Starnes, MD Jean E. Starr, MD Robert C. Steppacher, MD Michael C. Stoner, MD Rishi Subbarayan, MD Varuna Sundaram, MD Susan Golden Jacobson and Michael Golden Charitable Trust Matthew P. Sweet, MD Gale L. Tang, M.D. Gary Tannenbaum, MD Marcelo Passos Teivelis, MD, PhD Thomas T. Terramani, MD Theodore H. Teruya, MD Fabio A. Tornquist Sr., MD
Hoang S. Tran, MD, RVT, RPVI Shirling Tsai, MD Arthelma Chenee Tyson, MD Edith Tzeng, MD Areck Ucuzian, MD, PhD Naoki Unno, MD Patrick S. Vaccaro, MD José Vidoedo, MD Paul A. Vieta Jr., MD Gilford S. Vincent, MD Felix G. Vladimir, MD Grace J. Wang, MD Jinsong Wang, MD, PhD Fred A. Weaver, MD John V. White, MD Paul W. White, MD Rodney A. White, MD Karen Woo, MD Xenophon Paraskev Xenophontos, MD Anson A. Yeager, MD Shariq Zaidi, MD Mohamed A. Zayed, MD, PhD Jack Zeltzer, MD Wei Zhou, MD
AWARENESS & PREVENTION FUND
Samuel S. Ahn, MD Amy Chenoweth Delton L. Farquharson, MBBS, FRCSC, FACS Amit Jain, MD Neeta Karani, MD Madhusudanan Nair, MD Grace J. Wang, MD Jessica Williams, MD CLOWES DISTINGUISHED LECTURE FUND
Luke Packard Brewster, MD, PhD DISASTER RELIEF FUND
Raghu L. Motaganahalli, MD
RESEARCH FUND
Beth Bales Michael J. Beezley, MD Jayer Chung, MD Matthew Corriere, MD Scott Michael Damrauer, MD Delton L. Farquharson, MBBS, FRCSC, FACS Vivian Gahtan, MD Fredrick W. Gantz Philip P. Goodney, MD Rose Anna Hendricks Peter K. Henke, MD Karen J. Ho, MD Paula S. Johnson Gregory J. Landry, MD Joseph L. Mills, MD Firas F. Mussa, MD, MS, FACS Shannon E. O’Connor C. Keith Ozaki, MD Caron B. Rockman, MD Bryan W. Tillman, MD Gilbert R. Upchurch Jr., MD Esther A. Weber Karen Woo, MD Dai Yamanouchi, MD
13
How to Give to the SVS Foundation Our supporters enable the SVS Foundation to fulfill its mission to support not only the next generation of surgeon-scientists but also education, patient awareness and disease prevention.
Cash Can be done using check, credit card, or while paying your dues!
Stock Tax-Deductible
IRA Rollover
Industry Support
If over 70.5 years of age, you can lower your taxes on IRA withdrawals when you give
We invite industry to partner on education, research and patient awareness efforts
Other Gifts Including Wills/ Revocable Trusts, Life Insurance, Charitable Gift Annuities
Please help us help our vascular families—our patients, our researchers and everyone in between. Donate now at vsweb.org/GIVE.
Š2019 Society for Vascular Surgery Foundation 9400 W. Higgins Road, Suite 315 Rosemont, IL 60018-4975 Phone: 312-334-2300 / 800-258-7188